BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 18613858)

  • 1. Comparison of follitropin-beta administered by a pen device with conventional syringe in an ART programme - a retrospective study.
    Rama Raju GA; Suryanarayana K; Jaya Prakash G; Murali Krishna K
    J Clin Pharm Ther; 2008 Aug; 33(4):401-7. PubMed ID: 18613858
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An open, randomized single-centre study to compare the efficacy and convenience of follitropin beta administered by a pen device with follitropin alpha administered by a conventional syringe in women undergoing ovarian stimulation for IVF/ICSI.
    Platteau P; Laurent E; Albano C; Osmanagaoglu K; Vernaeve V; Tournaye H; Camus M; Van Steirteghem A; Devroey P
    Hum Reprod; 2003 Jun; 18(6):1200-4. PubMed ID: 12773446
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comparison of the efficacy, tolerability, and convenience of two formulations of follitropin-alpha in Iranian woman undergoing intracytoplasmic sperm injection cycles.
    Aghssa MM; Azargoon A; Ramezanzadeh F; Bagheri M
    Fertil Steril; 2008 Oct; 90(4):1043-8. PubMed ID: 18053995
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Patient and nurse evaluation of recombinant human follicle-stimulating hormone administration methods: comparison of two follitropin injection pens.
    Porter R; Kissel C; Saunders H; Keck C
    Curr Med Res Opin; 2008 Mar; 24(3):727-35. PubMed ID: 18230195
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Clinical application of prefilled pen and conventional syringe during controlled ovarian stimulation for in vitro fertilization].
    Chen LN; Quan S; Li H; Yang XP; Chen SM; Zhang XY; Lin L; Xing FQ; Chen SL; Wan ZJ; Wang Y
    Nan Fang Yi Ke Da Xue Xue Bao; 2009 Jan; 29(1):100-4. PubMed ID: 19218125
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of GnRH agonists and antagonists in normoresponder IVF/ICSI in Turkish female patients.
    Moraloglu O; Kilic S; Karayalçin R; Yuksel B; Tasdemir N; Işik A; Ugur M
    Adv Ther; 2008 Mar; 25(3):266-73. PubMed ID: 18345521
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A relative reduction in mid-follicular LH concentrations during GnRH agonist IVF/ICSI cycles leads to lower live birth rates.
    Lahoud R; Al-Jefout M; Tyler J; Ryan J; Driscoll G
    Hum Reprod; 2006 Oct; 21(10):2645-9. PubMed ID: 16785261
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Initiation of GnRH antagonist on Day 1 of stimulation as compared to the long agonist protocol in PCOS patients. A randomized controlled trial: effect on hormonal levels and follicular development.
    Lainas TG; Petsas GK; Zorzovilis IZ; Iliadis GS; Lainas GT; Cazlaris HE; Kolibianakis EM
    Hum Reprod; 2007 Jun; 22(6):1540-6. PubMed ID: 17347165
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Myo-inositol may improve oocyte quality in intracytoplasmic sperm injection cycles. A prospective, controlled, randomized trial.
    Papaleo E; Unfer V; Baillargeon JP; Fusi F; Occhi F; De Santis L
    Fertil Steril; 2009 May; 91(5):1750-4. PubMed ID: 18462730
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of two different fixed doses of follitropin-beta in controlled ovarian hyperstimulation: A prospective randomized, double blind clinical trial.
    Pruksananonda K; Suwajanakorn S; Sereepapong W; Virutamasen P
    J Med Assoc Thai; 2004 Oct; 87(10):1151-5. PubMed ID: 15560689
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Administration of recombinant human FSH (solution in cartridge) with a pen device in women undergoing ovarian stimulation.
    Pang S; Kaplan B; Karande V; Westphal LM; Scott R; Givens C; Sacks P;
    Reprod Biomed Online; 2003 Oct; 7(3):319-26. PubMed ID: 14653893
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Patient experience with follitropin alfa prefilled pen versus previously used injectable gonadotropins for ovulation induction in oligoanovulatory women.
    Somkuti SG; Schertz JC; Moore M; Ferrande L; Kelly E;
    Curr Med Res Opin; 2006 Oct; 22(10):1981-96. PubMed ID: 17022858
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of the efficacy and safety of a new recombinant human follicle-stimulating hormone (DA-3801) with follitropin-alpha (Gonal-F) in women undergoing controlled ovarian hyperstimulation for assisted reproductive technology.
    Moon SY; Choi YS; Ku SY; Kim SH; Choi YM; Kang IS; Kim CH
    J Obstet Gynaecol Res; 2007 Jun; 33(3):305-15. PubMed ID: 17578360
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Microdose gonadotropin-releasing hormone agonist flare-up protocol versus multiple dose gonadotropin-releasing hormone antagonist protocol in poor responders undergoing intracytoplasmic sperm injection-embryo transfer cycle.
    Kahraman K; Berker B; Atabekoglu CS; Sonmezer M; Cetinkaya E; Aytac R; Satiroglu H
    Fertil Steril; 2009 Jun; 91(6):2437-44. PubMed ID: 18555238
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Follitropin-alpha (Gonal-F) versus follitropin-beta (Puregon) in controlled ovarian hyperstimulation for in vitro fertilization: is there any difference?
    Orvieto R; Nahum R; Rabinson J; Ashkenazi J; Anteby EY; Meltcer S
    Fertil Steril; 2009 Apr; 91(4 Suppl):1522-5. PubMed ID: 18851846
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Performance of different ovarian reserve markers for predicting the numbers of oocytes retrieved and mature oocytes.
    Lorusso F; Vicino M; Lamanna G; Trerotoli P; Serio G; Depalo R
    Maturitas; 2007 Apr; 56(4):429-35. PubMed ID: 17184937
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of follitropin β administered by a pen device with follitropin β administered by a conventional syringe in patients undergoing IVF-ET.
    Kang HJ; Kim CH; Ahn JW; Lee HA; Kim SH; Chae HD; Kang BM
    Clin Exp Reprod Med; 2011 Mar; 38(1):37-41. PubMed ID: 22384416
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of a pen device for self-administration of recombinant human FSH in clomiphene citrate-resistant anovulatory women undergoing ovulation induction.
    Kettel LM; Scholl G; Bonaventura L; Pang S; Sacks P; Chantilis S; Mahony M;
    Reprod Biomed Online; 2004 Oct; 9(4):373-80. PubMed ID: 15511333
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum human chorionic gonadotropin level after ovulation triggering is influenced by the patient's body mass index and the number of larger follicles.
    Detti L; Mitwally MF; Rode A; Yelian FD; Kruger M; Diamond MP; Puscheck EE
    Fertil Steril; 2007 Jul; 88(1):152-5. PubMed ID: 17418834
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Criteria of a successful coasting protocol for the prevention of severe ovarian hyperstimulation syndrome.
    Mansour R; Aboulghar M; Serour G; Amin Y; Abou-Setta AM
    Hum Reprod; 2005 Nov; 20(11):3167-72. PubMed ID: 16006465
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.